The Manufacturers Life Insurance Company Acquires Shares of 10,910 LeMaitre Vascular, Inc. $LMAT

The Manufacturers Life Insurance Company bought a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,910 shares of the medical instruments supplier’s stock, valued at approximately $1,047,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Kennedy Capital Management LLC grew its position in LeMaitre Vascular by 14.8% during the fourth quarter. Kennedy Capital Management LLC now owns 247,907 shares of the medical instruments supplier’s stock worth $20,105,000 after buying an additional 32,040 shares in the last quarter. Wakefield Asset Management LLLP bought a new position in LeMaitre Vascular during the 4th quarter worth $1,130,000. Riverbridge Partners LLC acquired a new position in LeMaitre Vascular in the 1st quarter valued at $11,528,000. Vanguard Group Inc. lifted its position in shares of LeMaitre Vascular by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 1,622,033 shares of the medical instruments supplier’s stock valued at $131,547,000 after acquiring an additional 21,946 shares during the period. Finally, Conestoga Capital Advisors LLC lifted its position in shares of LeMaitre Vascular by 3.6% during the 1st quarter. Conestoga Capital Advisors LLC now owns 1,476,813 shares of the medical instruments supplier’s stock valued at $161,224,000 after acquiring an additional 51,825 shares during the period. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on LMAT. Wells Fargo & Company decreased their price target on LeMaitre Vascular from $104.00 to $94.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 5th. Citigroup reaffirmed a “market outperform” rating on shares of LeMaitre Vascular in a research report on Tuesday, July 21st. Weiss Ratings downgraded shares of LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, August 14th. Zacks Research cut shares of LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Finally, Barrington Research cut shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 5th. Three research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $110.60.

LeMaitre Vascular Price Performance

LeMaitre Vascular stock opened at $80.67 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 13.96 and a current ratio of 16.31. LeMaitre Vascular, Inc. has a 52 week low of $78.27 and a 52 week high of $118.01. The stock has a market capitalization of $1.84 billion, a P/E ratio of 28.31, a price-to-earnings-growth ratio of 2.32 and a beta of 0.50. The stock has a fifty day moving average of $91.88 and a 200-day moving average of $99.10.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.07). The business had revenue of $70.38 million for the quarter, compared to the consensus estimate of $71.47 million. LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%.LeMaitre Vascular’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.60 earnings per share. On average, sell-side analysts expect that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were issued a $0.25 dividend. The ex-dividend date of this dividend was Thursday, August 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.2%. LeMaitre Vascular’s dividend payout ratio is 35.09%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.